| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.36B | 32.26B | 25.75B | 24.04B | 19.69B | 20.71B |
| Gross Profit | 25.25B | 32.26B | 25.52B | 23.78B | 19.43B | 20.51B |
| EBITDA | 9.92B | 0.00 | 9.36B | 8.32B | 5.46B | 6.10B |
| Net Income | 7.08B | 10.44B | 6.72B | 5.55B | 3.56B | 3.76B |
Balance Sheet | ||||||
| Total Assets | 192.50B | 213.03B | 185.45B | 208.11B | 183.51B | 182.48B |
| Cash, Cash Equivalents and Short-Term Investments | 6.96B | 8.50B | 10.23B | 10.17B | 10.27B | 16.58B |
| Total Debt | 17.53B | 7.40B | 26.01B | 30.40B | 33.40B | 29.04B |
| Total Liabilities | 126.19B | 138.73B | 117.75B | 141.77B | 125.95B | 125.98B |
| Stockholders Equity | 66.31B | 74.30B | 67.70B | 66.34B | 57.56B | 56.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.91B | -6.41B | 1.05B | -5.89B | 5.93B |
| Operating Cash Flow | 0.00 | 16.96B | 3.13B | 1.58B | -5.80B | 6.36B |
| Investing Cash Flow | 0.00 | -455.00M | -666.00M | 3.02B | -2.39B | -1.14B |
| Financing Cash Flow | 0.00 | -4.42B | -2.82B | -1.89B | -1.73B | -2.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥87.85B | 6.96 | ― | 5.75% | 30.59% | 55.29% | |
70 Outperform | ¥203.98B | 4.29 | ― | 4.01% | 21.03% | 85.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥2.05T | 10.14 | 9.37% | 4.13% | 6.95% | 15.03% | |
65 Neutral | ¥233.92B | 13.77 | 14.00% | 5.13% | 34.33% | 47.34% | |
59 Neutral | ¥3.60T | 11.81 | 10.23% | 3.93% | 0.46% | 6.87% | |
43 Neutral | ¥171.33B | 13.27 | 7.26% | 4.16% | 9.77% | -52.42% |